Regulatory Approval (Pre-NCLT Clearance)
Sammaan Capital receives NSE & BSE “No Objection” for demerger scheme with Sammaan Finserve
NSE
sammaancap
BSE
535789
Sammaan Capital Limited has received “no objection” from NSE and “no adverse observations” from BSE for its proposed scheme of arrangement involving the demerger of lending business from Sammaan Finserve, enabling the company to proceed with filing the scheme before NCLT.
PRICE-SENSITIVE TRIGGER
Event: Receipt of observation letters from NSE & BSE
Type: Regulatory Approval (Pre-NCLT Clearance)
Impact: Positive
Immediate Effect: Clears a critical regulatory hurdle, allowing the company to move forward with the demerger process
Key Metrics
- Exchanges: NSE (No Objection), BSE (No Adverse Observation)
- Scheme Type: Demerger (Lending business transfer)
- Entities: Sammaan Finserve → Sammaan Capital
Highlight:
- Key milestone achieved: Exchange-level approval for scheme progression
What Happened ?
Sammaan Capital Limited has received observation letters from stock exchanges—“no adverse observations” from BSE and “no objection” from NSE—regarding its proposed scheme of arrangement with Sammaan Finserve Limited. This allows the company to proceed with filing the scheme before the National Company Law Tribunal (NCLT).
key highlights
Scheme Structure:
- Demerger of lending business from Sammaan Finserve (SFL)
- Transfer to Sammaan Capital (SCL) as a going concern
Regulatory Progress:
- NSE: Issued No Objection letter
- BSE: Issued No Adverse Observation letter
- Validity: 6 months to file with NCLT
Next Steps:
- Filing petition before NCLT
- Incorporation of SEBI/exchange observations
- Shareholder and creditor approvals
Compliance Conditions:
- No changes to scheme without SEBI approval
- Full disclosure of legal proceedings
- Continuous compliance reporting
Note:
- This is not final approval, but a critical step before NCLT clearance
Risk Analysis
Key Risks
- NCLT approval pending
- Potential modifications based on regulatory feedback
- Execution complexity in demerger
- Stakeholder approval risks
Worst Case Scenario
- If NCLT rejects or modifies the scheme significantly, the restructuring timeline and benefits may be delayed
Risk Level: Medium
Company Commentary
- Received exchange observation letters
- Scheme progressing as per SEBI LODR norms
- Next step: Filing before NCLT
- Disclosure hosted on company website
Official Exchange Filing: Sammaan Capital Limited